Gynecomastia and breast cancer during finasteride therapy [6]

New England Journal of Medicine

Volumn 335, Issue 11, 1996, Pages 823-

  Green, L ^a   Wysowski, D K ^a   Fourcroy, J L ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; DIGOXIN; FINASTERIDE; HISTAMINE H2 RECEPTOR ANTAGONIST; MEVINOLIN; SPIRONOLACTONE; TESTOSTERONE; VERAPAMIL;

ADULT; AGED; BREAST CANCER; DISEASE ASSOCIATION; DRUG MECHANISM; DRUG MONITORING; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; GYNECOMASTIA; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; UNITED STATES;

BREAST NEOPLASMS, MALE; FINASTERIDE; GYNECOMASTIA; HUMANS; MALE; PROSTATIC HYPERPLASIA;

EID: 0029835393     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199609123351116     Document Type: Letter

References (0)